Arkolith/Insider Trading/VIVO/Form 4

Kenny John P.

Chief Executive Officer, DirectorMERIDIAN BIOSCIENCE INC (VIVO) · full profile →Form 4 · filed Feb 17, 2021
Net Selling
Open-Market Buys
$0
Open-Market Sells
$72K
Net Open-Market Flow
-$72K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 16, 2021Option exercise(M)2K$10.10$21K251K
Feb 16, 2021Sell(S)2K$30.35$72K249K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 16, 2021Option exercise(M)2K—$0156K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001127602-21-006067) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML

Keep exploring

Connected pages for MERIDIAN BIOSCIENCE INC

Build

Ask your agent about VIVO insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Get a key Compare plansForm 4 data
Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0001127602-21-006067"
Ask your agent
Use Arkolith to summarize insider buying and selling at MERIDIAN BIOSCIENCE INC
over the last 90 days and cite the filings.